JPRN-jRCTs041190054已完成未知
Effects of Omega-3 fatty acids for schizophrenia and at-risk mental state
Higuchi Yuko0 个研究点目标入组 0 人开始时间: 2019年7月22日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 16age old 至 < 50age old（—）
- 性别
- All
入选标准
- •(1) Schizophrenia patients, fulfilled the criteria of DSM-5, (2) ARMS patients, fulfilled the criteria of CAARMS(the Comprehensive Assessment of At-Risk Mental State)
排除标准
- •(1)Organic mental disorders, including epilepsy, having the history of head injury or alcohol dependence, (2)bleeding tendency or GI bleeding, (3)Mental retardation, (4)Infant(aged below 15 years old)
研究者
相似试验
已完成
1 期
Efficacy of Omega-3 in the treatment of SchizophreniaSchizophrenia.The Schizophrenic Disorders Are Characterized in general by fundamental and characteristic distortions of thinking and perception, and affects that are inappropriate or blunted.IRCT201202117373N2Arak University Of Medical Sciences60
已完成
2 期
Decreasing Risk of Coronary Artery Disease in Schizophrenia by Omega-3 Fatty Acid SupplementationMajor DepressionCoronary Artery DiseaseSchizophreniaBipolar DisorderSchizoaffective DisorderNCT00167310University of Pittsburgh57
Unknown
4 期
Omega-3 Fatty Acids Efficacy in First-episode of SchizophreniaSchizophreniaNCT02210962Medical University of Lodz80
已完成
不适用
Omega 3 Fatty Acids in the Treatment of Children With Autism Spectrum DisordersAutismNCT00467818University of Medicine and Dentistry of New Jersey17
已完成
4 期
Indicated Prevention With Omega-3 Fatty Acids in Adolescents With 'At-Risk-Mental-State' for PsychosisProdromeSchizophreniaNCT00396643Medical University of Vienna81